Edition:
United Kingdom

Hansa Medical AB (HMED.ST)

HMED.ST on Stockholm Stock Exchange

245.60SEK
23 May 2018
Change (% chg)

-7.40kr (-2.92%)
Prev Close
253.00kr
Open
252.60kr
Day's High
252.60kr
Day's Low
245.20kr
Volume
52,654
Avg. Vol
104,259
52-wk High
290.00kr
52-wk Low
158.00kr

Select another date:

Wed, Apr 25 2018

BRIEF-Hansa Medical Q1 Operating Loss Widens To SEK 46.6 Million

* Q1 OPERATING LOSS SEK 46.6 MILLION VERSUS LOSS SEK 44.8 MILLION YEAR AGO

BRIEF-Hansa Medical Appoints Søren Tulstrup New President And CEO

* SØREN TULSTRUP APPOINTED NEW PRESIDENT AND CEO OF HANSA MEDICAL

BRIEF-Hansa Medical Granted Orphan Drug Designation By FDA

* HANSA MEDICAL RECEIVES FDA ORPHAN DRUG DESIGNATION FOR IDES AND THE TREATMENT OF GUILLAIN-BARRÉ SYNDROME Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Hansa Medical AB Q4 Net Revenue Sek 1.0 ‍​ Million Versus Sek 0.5 Million Year Ago

* Q4 NET REVENUE SEK 1.0 ‍​ MILLION VERSUS SEK 0.5 MILLION YEAR AGO

BRIEF-‍Hansa Medical's board has resolved on a directed share issue of SEK 545 mln​

* ‍HANSA MEDICAL'S BOARD OF DIRECTORS HAS RESOLVED ON A DIRECTED SHARE ISSUE OF SEK 545 MILLION​ Source text for Eikon: Further company coverage:

BRIEF-‍Hansa Medical Contemplates Directed Share Issue To Raise About Sek 545 mln​

* ‍HANSA MEDICAL CONTEMPLATES A DIRECTED SHARE ISSUE TO RAISE APPROXIMATELY SEK 545 MILLION​

Select another date: